• LAST PRICE
    6.9800
  • TODAY'S CHANGE (%)
    Trending Up0.0200 (0.2874%)
  • Bid / Lots
    6.6900/ 2
  • Ask / Lots
    7.0900/ 3
  • Open / Previous Close
    6.9000 / 6.9600
  • Day Range
    Low 6.8000
    High 7.0700
  • 52 Week Range
    Low 6.8000
    High 28.2600
  • Volume
    411,575
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 6.96
TimeVolumeSAGE
09:32 ET28026.94
09:34 ET102566.896
09:36 ET4006.9
09:38 ET17506.93
09:39 ET2006.9
09:41 ET1006.89
09:43 ET37746.8624
09:45 ET1006.84
09:48 ET3096.84
09:54 ET12326.84
09:56 ET6006.81
09:57 ET7636.825
09:59 ET253646.92
10:01 ET284436.95
10:06 ET9237
10:08 ET9006.95
10:10 ET10737.01
10:12 ET11827.01
10:14 ET2007.015
10:15 ET2007
10:17 ET7007.01
10:19 ET8237.02
10:21 ET2007.02
10:24 ET7007
10:26 ET4007.01
10:28 ET7807.02
10:32 ET4476.999
10:33 ET7087.01
10:39 ET5006.995
10:42 ET6096.99
10:44 ET10827
10:46 ET2007.005
10:48 ET2007.02
10:50 ET1187.03
10:51 ET6007.06
10:53 ET28847.04
10:57 ET3007.04
11:02 ET17007.04
11:04 ET2277.04
11:06 ET17977.05
11:08 ET4417.06
11:09 ET12007.04
11:11 ET2007.035
11:13 ET6007.02
11:18 ET2507.005
11:20 ET1007.005
11:22 ET6307.015
11:24 ET3737
11:27 ET7006.98
11:29 ET2006.985
11:31 ET1006.985
11:33 ET8547.01
11:36 ET1007.01
11:38 ET16407.02
11:40 ET4527.02
11:44 ET1007.02
11:45 ET3007.05
11:47 ET20027.04
11:49 ET11387.055
11:54 ET1007.06
11:56 ET14497.03
11:58 ET4347.03
12:00 ET19047.05
12:02 ET1007.05
12:07 ET7007.04
12:09 ET2007.05
12:12 ET1007.04
12:14 ET2707.04
12:18 ET7007.03
12:20 ET12007.03
12:21 ET3007.03
12:23 ET7917.04
12:27 ET2007.04
12:32 ET4357.04
12:34 ET3007.04
12:36 ET16117.019
12:38 ET2007
12:39 ET7677
12:41 ET8757.012
12:43 ET3006.99
12:45 ET2056.99
12:48 ET27006.98
12:50 ET6006.96
12:52 ET25086.94
12:54 ET1156.95
12:56 ET2006.95
12:57 ET13716.95
12:59 ET11466.93
01:01 ET8906.94
01:03 ET5306.94
01:06 ET3006.94
01:08 ET9106.955
01:10 ET3916.95
01:12 ET16246.92
01:14 ET1006.91
01:15 ET4006.91
01:17 ET8526.91
01:19 ET1006.91
01:21 ET10606.94
01:24 ET9006.94
01:26 ET4006.92
01:28 ET1636.92
01:30 ET6816.9398
01:32 ET21736.9267
01:33 ET26356.93
01:35 ET8876.92
01:37 ET21986.92
01:39 ET4736.93
01:42 ET6116.93
01:44 ET1006.94
01:46 ET1006.95
01:50 ET3006.97
01:51 ET3636.9797
01:53 ET4666.98
01:55 ET3007
01:57 ET6537
02:00 ET3007
02:02 ET2007
02:04 ET3007.03
02:06 ET4007.02
02:08 ET14587.015
02:09 ET1767.0254
02:11 ET1007.03
02:13 ET5637.03
02:15 ET11007.045
02:18 ET2007.045
02:20 ET1007.05
02:22 ET11007.025
02:24 ET3337.0397
02:26 ET2007.04
02:27 ET1627.025
02:29 ET10007.01
02:31 ET1007.005
02:33 ET9447.02
02:38 ET1007.03
02:42 ET1657.03
02:44 ET3007.03
02:45 ET13747.03
02:47 ET4467.02
02:49 ET1007.03
02:51 ET3007.03
02:54 ET16857.01
02:56 ET2067.01
02:58 ET1007
03:00 ET10007
03:02 ET8346.999
03:03 ET14837.02
03:05 ET9007.025
03:07 ET19037.02
03:09 ET1007.015
03:12 ET7007.01
03:14 ET20637
03:16 ET10457
03:18 ET3007.01
03:20 ET4817
03:21 ET5887.01
03:23 ET10007.01
03:25 ET13107.01
03:27 ET9447.005
03:30 ET11827.005
03:32 ET14327.01
03:34 ET23327.02
03:36 ET11007.04
03:38 ET12007.04
03:39 ET16697.04
03:41 ET17557.04
03:43 ET22147.025
03:45 ET20857.03
03:48 ET7007.025
03:50 ET43386.99
03:52 ET19257
03:54 ET24126.99
03:56 ET41846.995
03:57 ET38406.985
03:59 ET822516.98
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesSAGE
SAGE Therapeutics Inc
424.9M
-0.9x
---
United StatesGRAL
Grail Inc
411.4M
-0.1x
---
United StatesALEC
Alector Inc
442.8M
-2.5x
---
United StatesRGNX
Regenxbio Inc
504.6M
-1.9x
---
United StatesURGN
Urogen Pharma Ltd
525.6M
-3.8x
---
United StatesCDXC
Chromadex Corp
270.3M
-192.8x
---
As of 2024-10-03

Company Information

Sage Therapeutics, Inc. is a biopharmaceutical company. The Company has developed the two FDA-approved treatments indicated for postpartum depression and is advancing a robust pipeline to target unmet needs in brain health. The Company is targeting diseases and disorders of the brain across its clinical development and earlier stage pipeline. Its product ZURZUVAE is for the treatment of postpartum depression (PPD) in adults. ZURZUVAE is a neuroactive steroid that is a positive allosteric modulator of GABA receptors, targeting both synaptic and extra synaptic GABA receptors. Its product ZULRESSO (brexanolone) CIV injection is for the treatment of PPD in individuals 15 years old and older. It is also developing a portfolio of other novel compounds that target GABA receptors, including SAGE-324, which is a novel GABAA receptor positive allosteric modulator intended for chronic oral dosing. Its second area of focus for development is novel compounds that target the NMDA receptor.

Contact Information

Headquarters
215 1st StCAMBRIDGE, MA, United States 02142-1213
Phone
617-299-8380
Fax
617-299-8379

Executives

Independent Chairman of the Board
Geno Germano
President, Chief Executive Officer, Director
Barry Greene
Chief Financial Officer, Treasurer
Kimi Iguchi
Senior Vice President, General Counsel
Anne Cook
Chief Business Officer
Christopher Benecchi

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$424.9M
Revenue (TTM)
$97.2M
Shares Outstanding
61.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.91
EPS
$-7.41
Book Value
$13.32
P/E Ratio
-0.9x
Price/Sales (TTM)
4.4
Price/Cash Flow (TTM)
---
Operating Margin
-496.58%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.